Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics.

Addiction research ethics and the Belmont principles: do drug users have a different moral voice? Subst Use Misuse (2010) 1.08

Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. Soc Sci Med (2015) 0.95

Cluster randomized controlled trial protocol: addressing reproductive coercion in health settings (ARCHES). BMC Womens Health (2015) 0.79

Ushering in another harm reduction era? Discursive authenticity, drug policy and research. Drug Alcohol Rev (2005) 0.78

Moral frameworks, ethical engagement and harm reduction: commentary on 'Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics' by C. L. Fry, C. Treloar & L. Maher. Drug Alcohol Rev (2005) 0.75

Harm reduction ethics: a promising basis for drug policy. Drug Alcohol Rev (2005) 0.75

We still need communitarian ethics in harm reduction research. Drug Alcohol Rev (2006) 0.75

Ethical challenges and responses in harm reduction research: a critique of applied communitarian ethics. Drug Alcohol Rev (2006) 0.75

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14

Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog (2011) 2.13

Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis (2011) 1.74

The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev (2007) 1.65

'It's more about the heroin': injection drug users' response to an overdose warning campaign in a Canadian setting. Addiction (2013) 1.56

The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction (2010) 1.51

Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol (2012) 1.39

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis (2005) 1.36

Single index of multimorbidity did not predict multiple outcomes. J Clin Epidemiol (2005) 1.25

The social production of hepatitis C risk among injecting drug users: a qualitative synthesis. Addiction (2008) 1.24

Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend (2011) 1.21

Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis (2013) 1.19

How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18

Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia. BMJ Open (2013) 1.18

Rural general practitioner apprehension about work related violence in australia. Aust J Rural Health (2003) 1.15

Prisons, hepatitis C and harm minimisation. Med J Aust (2007) 1.14

Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis (2012) 1.13

Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS (2012) 1.11

Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning. Addiction (2009) 1.10

Injection drug users' involvement in drug dealing in the downtown eastside of Vancouver: social organization and systemic violence. Int J Drug Policy (2013) 1.09

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study. Clin Infect Dis (2013) 1.09

Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend (2007) 1.08

The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care (2012) 1.05

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis. J Acquir Immune Defic Syndr (2009) 1.04

Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting. Drug Alcohol Depend (2009) 1.00

Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction (2006) 0.99

A prospective study of hepatitis C incidence in Australian prisoners. Addiction (2014) 0.99

Extending drug ethno-epidemiology using agent-based modelling. Addiction (2009) 0.98

Resilient coping: applying adaptive responses to prior adversity during treatment for hepatitis C infection. J Health Psychol (2008) 0.97

Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. J Acquir Immune Defic Syndr (2008) 0.97

Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. J Urban Health (2008) 0.97

Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug Alcohol Rev (2010) 0.96

The effectiveness of harm reduction in preventing HIV among injecting drug users. N S W Public Health Bull (2010) 0.96

Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study. Am J Public Health (2013) 0.95

Equity of access to treatment, and barriers to treatment for illicit drug use in Australia. Addiction (2007) 0.94

Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health (2013) 0.93

Biomarker validation of recent unprotected sexual intercourse in a prospective study of young women engaged in sex work in Phnom Penh, Cambodia. Sex Transm Dis (2013) 0.93

Outreach for chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health (2013) 0.92

The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. J Gastroenterol Hepatol (2009) 0.92

Attitudes of men in an Australian male tolerance study towards microbicide use. Sex Health (2008) 0.91

The experience of interferon-based treatments for hepatitis C infection. Qual Health Res (2005) 0.90

Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Aust N Z J Public Health (2008) 0.90

The Indigenous Resiliency Project: a worked example of community-based participatory research. N S W Public Health Bull (2009) 0.89

Indigenous Australian medical students' perceptions of their medical school training. Med Educ (2009) 0.89

Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. Drug Alcohol Rev (2006) 0.89

Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions. Drug Alcohol Rev (2008) 0.89

Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney. Drug Alcohol Rev (2010) 0.88

A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med (2013) 0.88

Injecting-related injury and disease among clients of a supervised injecting facility. Drug Alcohol Depend (2009) 0.88

Addiction journal is committed to publishing qualitative research. Addiction (2013) 0.87

Drugs, public health and policing in indigenous communities. Drug Alcohol Rev (2004) 0.87

Under the watchful eye of 'a benevolent dictator' - general practitioner and patient experiences of hepatitis C treatment initiation and shared-care in general practice. Aust Fam Physician (2013) 0.87

HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment. J Acquir Immune Defic Syndr (2015) 0.86

Violence prevention and municipal licensing of indoor sex work venues in the Greater Vancouver Area: narratives of migrant sex workers, managers and business owners. Cult Health Sex (2015) 0.86

Mental health symptoms among street-based psychostimulant injectors in Sydney's Kings Cross. Subst Use Misuse (2010) 0.86

Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav (2007) 0.86

One size fits all? The discursive framing of cultural difference in health professional accounts of providing cancer care to Aboriginal people. Ethn Health (2013) 0.85

STI in remote communities: improved and enhanced primary health care (STRIVE) study protocol: a cluster randomised controlled trial comparing 'usual practice' STI care to enhanced care in remote primary health care services in Australia. BMC Infect Dis (2013) 0.85

Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Int J Drug Policy (2007) 0.85

HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment. Curr Opin HIV AIDS (2012) 0.85

Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008. Int J Drug Policy (2010) 0.85

Individual-level syringe coverage among Needle and Syringe Program attendees in Australia. Drug Alcohol Depend (2011) 0.85

Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: a review. Drug Alcohol Rev (2009) 0.84

Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction. AIDS (2014) 0.84

Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs. Drug Alcohol Depend (2011) 0.84

Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009. AIDS (2011) 0.84

From oxycodone to heroin: two cases of transitioning opioid use in young Australians. Drug Alcohol Rev (2013) 0.83

HIV and HCV among people who inject drugs in Central Asia. Drug Alcohol Depend (2013) 0.83

Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity. Cult Health Sex (2008) 0.83

Chronic illness experiences, clinical markers and living with hepatitis C. J Health Psychol (2007) 0.83

Are people who inject performance and image-enhancing drugs an increasing population of Needle and Syringe Program attendees? Drug Alcohol Rev (2012) 0.83

Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia. Addict Sci Clin Pract (2012) 0.83

Heroin-gel capsule cocktails and groin injecting practices among ethnic Vietnamese in Melbourne, Australia. Int J Drug Policy (2008) 0.82

Australian men's experiences during a microbicide male tolerance study. AIDS Care (2009) 0.82

Staying safe from hepatitis C: engaging with multiple priorities. Qual Health Res (2011) 0.82

Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs. Aust N Z J Public Health (2013) 0.82

Pleasure and drugs. Int J Drug Policy (2008) 0.82

At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion. Health Soc Care Community (2013) 0.81

Có vay có tra (What goes around comes around): culture, risk and vulnerability to blood-borne viruses among ethnic Vietnamese injecting drug users. Drug Alcohol Rev (2008) 0.81

Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand. Int J Integr Care (2012) 0.81

Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection. J Adv Nurs (2007) 0.81

Enhancing Aboriginal and Torres Strait Islander young people's resilience to blood-borne and sexually transmitted infections: findings from a community-based participatory research project. Health Promot J Austr (2009) 0.81

A diagnosis of hepatitis C - insights from a study on patients' experiences. Aust Fam Physician (2010) 0.81

Harm minimisation in Australian prisons--health protection still depends on where you serve your time. Med J Aust (2012) 0.80

Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey. Drug Alcohol Rev (2008) 0.80

Supervised injecting facilities: how much evidence is enough? Drug Alcohol Rev (2007) 0.80

"Fitness for duty": social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs. Vaccine (2010) 0.80

Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs. Aust N Z J Public Health (2011) 0.80

Hepatitis B vaccination and injecting drug use: narrowing the efficacy-effectiveness gap. Int J Drug Policy (2008) 0.80

Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study. Contemp Clin Trials (2009) 0.79

Abatacept therapy for rheumatoid arthritis in the setting of hepatitis C infection. J Clin Rheumatol (2010) 0.79

Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with hepatitis C. Soc Sci Med (2004) 0.79

Learning from the past: young Indigenous people's accounts of blood-borne viral and sexually transmitted infections as resilience narratives. Cult Health Sex (2011) 0.79

'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings. Addiction (2014) 0.79

Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia. Drug Alcohol Rev (2010) 0.79

Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs. Drug Alcohol Rev (2012) 0.79